Development of innovative medicines and medical technologies for complex diseases, including oncology, immunology, neuroscience, cardiopulmonary, and specialty ophthalmology.
B
CSR Analysis score
The organization is among the top 20% of most committed organizations, excluding the top 5%, among comparable organizations.
+160,000
Total organizations analyzedAnalysis by axis
Access the detailed report with all sector benchmarks, in-depth competitive analysis and actionable recommendations.
Methodology: Score calculated according to 6 CSR themes (Carbon, Biodiversity, Circular Economy, Sustainable Investments, Governance, Social Impact)
Sources: Public data, CSR reports, documented initiatives, official databases
Last update: February 2026
This analysis is not yet available in English. Please see the French version.
Leading organizations
Takeda
B
Development and commercialization of innovative medicines in various therapeutic areas, including gastrointestinal diseases, rare diseases, plasma-derived therapies, oncology, neuroscience, and vaccines.
Sanofi
B
Development of innovative medicines and vaccines to improve patients' lives, focusing on areas like immunology, oncology, rare diseases, and vaccines.
Siemens Healthineers
A
Development of innovative medical technologies for diagnostics, treatment, and disease management, including imaging, in vitro diagnostics, image-guided therapy, and cancer care.
Initiatives identified among leaders
Réduire les émissions de gaz à effet de serre dans la production et l'utilisation des produits
“Siemens Healthineers réduit les émissions de gaz à...” - Siemens HealthineersUnité de santé mondiale
“L'unité de santé mondiale de Sanofi pasteur fourni...” - SanofiPromotion des droits de l'homme
“Takeda promeut les droits de l'homme dans toutes l...” - Takeda38% of similar organizations communicate on CSR issues
+1674 initiatives collected from 50 similar organizations
Is your score incomplete? Update your CSR information and improve your positioning.
Claim this page
Updated data
Personalized recommendations
Access complete data, competitive analyses and actionable recommendations for your clients.
Comprehensive sector benchmarks
Competitive data
Ready-to-use reports